基于 2 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the full record of transactions filed by Capper Joseph H. Officer active across 5 companies, notably Neuronetics, Inc.. Cumulatively, 13 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €1.5m. History available since 1 January 2023. The latest transaction was disclosed on 15 July 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Capper Joseph H has 11 filings in total. Across the 11 filings we hold, buys total 1457454 EUR, sells are 0 EUR, and the period runs from 2023-01-04 to 2026-06-23. He is Director at Anika Therapeutics, Inc. and TELA Bio, Inc., Chief Executive Officer at Mimedx Group, INC., and Director at Neuronetics, Inc. The main filings listed include a buy of 1122471.683661893 EUR at Mimedx Group, INC. on 2025-05-05 and a buy of 334981.9462458101 EUR at Mimedx Group, INC. on 2023-06-26.